ABMCinactive

AMERICAN BIO MEDICA CORP

Healthcare·Healthcare·Commercial·CEO: Melissa A. Waterhouse
7.7/10

BioSniper Score

4-factor signal

Market Cap

—

Cash Runway

2.0 mo

Lead Asset

'rapid drug screen' 8 panel-low volume

Next Catalyst

—

AMERICAN BIO MEDICA CORP: 31 pipeline candidates · Updated within the last hour.

Go deeper on AMERICAN BIO MEDICA CORP with Spotter

Ask follow-up questions and run a full multi-agent deep dive on ABMC — live, with citations.

Ask Spotter

Score breakdown4-factor signal · derived from public data

Cash Runway0.6

2.0 months

Financial Health10.0

D/E -2.44 · 0% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth10.0

31 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

Key Financialsas of March 31, 2023

Cash

$68K

Quarterly Burn

$363K

Revenue

$164K

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Aug 2026
Today~7 mo out
Catalyst within runway

Pipeline (31 candidates)

DrugPhase
'rapid drug screen' 8 panel-low volume—
'rapid drug screen' 9-panel—
'rapid one' - propoxyphene test—
'rapidone'-methadone test—
'rapidtec 4' test—
'rapidtec' 5a multiple dip test—
'rapidtec'-5m-multiple dip test—
modification to 'rapid drug screen' 9-panel—
modification to rapid drug screen 9-panel—
oralstatApproved

Showing 10 of 31 candidates. Sign up for full pipeline.

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.

Get the full picture on AMERICAN BIO MEDICA CORP

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar